Has anyone dealt with international price comparison?

Dr.SurgeonPGH said:

Denials are usually procedural rather than clinical, and the order that works reflects that.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Adding it to my notes with a link back to this thread.

Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Worth separating that from cost and coverage, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Dr.LipidDallas said:

My experience ordering cross-border ordering internationally: I've ordered from an Australian compounder.

Pushing back on Dr.LipidDallas here. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

Correct me if the detail matters more than I have assumed.

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

Worth separating that from cost and coverage, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Moderator note: the sourcing question belongs in the vendor section and has been split out. Tagging this one for the weekly digest.